| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.915930 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240722124813 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 221004s2022 onc o f000 0 eng d |
|---|
| 020 | |a9780660457031 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-344/2022E-PDF |
|---|
| 245 | 00|aAccess Consortium : |boperational procedures for the generic medicines work-sharing initiative (GMWSI). |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2022. |
|---|
| 300 | |a1 online resource (i, 6 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Consortium Access : procédures opérationnelles pour l'initiative de partage du travail concernant les médicaments génériques (IPTMG). |
|---|
| 520 | |a"This document outlines operational procedures and recommendations for planning and implementing the Generic Medicines Work-sharing Initiative (GMWSI) for the regulatory agencies within the Access Consortium. The agencies are: Therapeutic Goods Administration (TGA), Australia; Health Canada (HC), Canada; Health Sciences Authority (HSA), Singapore; Swissmedic (SMC), Switzerland; Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom"--page 1. |
|---|
| 650 | 0|aDrugs|zCanada|xGeneric substitution. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tConsortium Access : |w(CaOODSP)9.915931 |
|---|
| 794 | |tAccess Consortium : |w(CaOODSP)9.940844 |
|---|
| 856 | 40|qPDF|s607 KB|uhttps://publications.gc.ca/collections/collection_2023/sc-hc/H164-344-2022-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/international-activities/access-consortium/operational-procedures-consortium-generic-medicines-work-sharing-initiative.html |
|---|
| 986 | |a220461 |
|---|